Walker Paul Edward insider trades
Walker Paul Edward has filed 27 Form 4s with the SEC that we hold, for NEUE (Director, 10% owner), ALLK (Director), Trevi Therapeutics, Inc. (TRVI) (10% owner) and Korro Bio, Inc. (KRRO) (10% owner), among 12 companies in all. Across all of them we count 10 purchases worth $54.1M and 8 sales worth $1.3M reported on Form 4. In the last 12 months: 2 purchases ($17.3M) and 0 sales ($0). The largest single trade was a purchase of 3,386,400 shares of ALLK worth $17.0M, dated 2022-09-21. The first filing on our record is dated 2021-10-14 and the latest 2026-03-12.
NEUE
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-02 | S, sale reported on Form 4 | 280 | $1.9K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 900 | $6.1K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 2,455 | $16.6K | 2025-10-06 |
ALLK
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-09-21 | P, purchase reported on Form 4 | 3,386,400 | $17.0M | 2022-09-23 |
| 2022-09-21 | P, purchase reported on Form 4 | 597,600 | $3.0M | 2022-09-23 |
Trevi Therapeutics, Inc. (TRVI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-18 | P, purchase reported on Form 4 | 1,851,852 | - | 2021-10-19 |
| 2022-04-11 | P, purchase reported on Form 4 | 948,948 | $1.8M | 2022-04-13 |
| 2022-04-11 | P, purchase reported on Form 4 | 2,631,578 | $5.0M | 2022-04-13 |
Korro Bio, Inc. (KRRO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-22 | P, purchase reported on Form 4 | 17,857 | $1,000.0K | 2024-04-24 |
| 2026-03-10 | P, purchase reported on Form 4 | 207,100 | $2.3M | 2026-03-12 |
AKUS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
GNCA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-24 | S, sale reported on Form 4 | 5,931,843 | $415.2K | 2022-05-26 |
| 2022-05-25 | S, sale reported on Form 4 | 4,445,093 | $355.6K | 2022-05-26 |
MBX Biosciences, Inc. (MBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-16 | P, purchase reported on Form 4 | 500,000 | $8.0M | 2024-09-17 |
MTCR
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-10 | S, sale reported on Form 4 | 37,570 | $49.6K | 2021-12-27 |
| 2021-12-22 | S, sale reported on Form 4 | 170,932 | $155.5K | 2021-12-27 |
| 2021-12-22 | S, sale reported on Form 4 | 288,768 | $288.8K | 2021-12-27 |
Mirum Pharmaceuticals, Inc. (MIRM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Savara Inc (SVRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-07-17 | P, purchase reported on Form 4 | 333,333 | $1,000.0K | 2023-07-19 |
SpyGlass Pharma, Inc. (SGP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-09 | P, purchase reported on Form 4 | 937,500 | $15.0M | 2026-02-11 |
TRIL
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1553150) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms